Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study

BACKGROUND: REGOBONE multicohort study explored the efficacy and safety of regorafenib for patients with advanced bone sarcomas; this report details the cohort of patients with relapsed advanced or metastatic chordoma. METHODS: Patients with relapsed chordoma progressing despite 0-2 prior lines of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Cesne, A., Chevreau, C., Perrin, C., Italiano, A., Hervieu, A., Blay, J.Y., Piperno-Neumann, S., Saada-Bouzid, E., Bertucci, F., Firmin, N., Kalbacher, E., Narciso, B., Schiffler, C., Yara, S., Jimenez, M., Bouvier, C., Vidal, V., Chabaud, S., Duffaud, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265601/
https://www.ncbi.nlm.nih.gov/pubmed/37285716
http://dx.doi.org/10.1016/j.esmoop.2023.101569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265601/
https://www.ncbi.nlm.nih.gov/pubmed/37285716
http://dx.doi.org/10.1016/j.esmoop.2023.101569

Ejemplares similares